We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

ATLANTA, GA—An implantable coronary sinus reducer (CSR) in patients with refractory angina significantly reduces symptoms over 6 months of follow-up compared with a placebo procedure, a new study ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

PARIS — After the first major prospective study to associate percutaneous intervention (PCI) with symptom relief in stable angina captured international attention, a new analysis of the ...

PARIS -- Whether a person had chest pains resolved by angioplasty hinged on the nature, not the severity, of their presenting symptoms, an ORBITA-2 analysis showed. Investigators found two groups more ...

Older patients enrolled in the ISCHEMIA trial saw their angina symptoms improve with an invasive strategy as compared with more-conservative management, but unlike younger patients in the trial, they ...

ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...

Left arm pain can be a sign of a heart attack or angina. A blood clot in the arm can cause the same symptoms and is an ...

Find out more about how Shexiang Tongxin Dropping Pill improved coronary blood flow in a multicentre randomised trial.

PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...